HK
Hemalatha Karri
About Hemalatha Karri
Data last updated:
Hemalatha Karri is a Director at Sunsecure Clinical Research Services Private Limited (since 2023). Sunsecure Clinical Research Services Private Limited reported revenue of ₹27.8 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sunsecure Clinical Research Services Private Limited U46497KA2023PTC176103 | Director | 17 Jul 2023 | 2023 | ₹27.8 Lakh (FY 2025) | Active |
Board colleagues of Hemalatha Karri
| Name | DIN | Company | Designation |
|---|---|---|---|
| Srilakshmi Sravani Pentakota | 10242304 | Sunsecure Clinical Research Services Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemalatha Karri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemalatha Karri
Hemalatha Karri currently holds 1 directorship: Sunsecure Clinical Research Services Private Limited (Director, since 17 Jul 2023, revenue ₹27.8 Lakh (FY 2025)).
Hemalatha Karri was first appointed on 17 Jul 2023 as Director at Sunsecure Clinical Research Services Private Limited.
The current boards of Hemalatha Karri's companies include Srilakshmi Sravani Pentakota (Sunsecure Clinical Research Services Private Limited).